What changes have been made to the recommendations on blood pressure targets and antithypertensive drug treatment for people with cardiovascular disease in March 2022?
We have reviewed the evidence on blood pressure targets for people with cardiovascular disease, and made a new recommendation. This is marked [2022]. We have also reassessed the evidence on antihypertensive drug treatment, and made a new recommendation for people with cardiovascular disease. This is marked [2022].